Dr. Lahti has extensive research experience with schizophrenia and the medications used to treat this disease. Her major research interests are psychopharmacology, the nature and treatment of schizophrenia, family studies of schizophrenia and brain imaging techniques. Dr. Lahti leads a multidisciplinary staff of psychiatrists, psychologists, a social worker, psychiatric nurses and rehabilitation specialists. This group utilizes a team approach in working with this challenging patient population during their stay. The Residential Research unit is a 20-bed, extended stay, inpatient program with patients admitted on average for an 8 to 12 month period.
Length of stay is determined by the needs of each individual.
The novel medication strategies, including short drug-free periods, are implemented within an environment that encourages learning experiences. Residents participate in group projects and daily activities that emphasize socialization and productivity. Family Involvement Active family involvement is an important aspect of this program. Family members are encouraged to participate in group meetings and social events. Regular meetings are held with families to discuss their family member's participation in research studies as well as findings and recommendations for future treatment.